118 related articles for article (PubMed ID: 6493192)
1. [Group I pepsinogen (PG I) in the serum and urine after total gastrectomy].
Kodama M; Takahashi T; Kida K; Yamaguchi T
Nihon Geka Gakkai Zasshi; 1984 Jul; 85(7):686-93. PubMed ID: 6493192
[TBL] [Abstract][Full Text] [Related]
2. Characterization of urinary peptic activity after total gastrectomy.
Yamaguchi T; Takahashi T; Kodama M
Jpn J Surg; 1990 Jan; 20(1):70-5. PubMed ID: 2304289
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
[TBL] [Abstract][Full Text] [Related]
4. Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum.
Samloff IM
Gastroenterology; 1982 Jan; 82(1):26-33. PubMed ID: 7053333
[TBL] [Abstract][Full Text] [Related]
5. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays.
Hengels KJ; Strohmeyer G
Z Gastroenterol; 1989 Aug; 27(8):406-11. PubMed ID: 2609705
[TBL] [Abstract][Full Text] [Related]
6. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer.
Samloff IM; Liebman WM; Panitch NM
Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038
[TBL] [Abstract][Full Text] [Related]
7. [The significance of pepsinogen with its subgroup and CA72-4 associate detect applied to early diagnostic and prognosis judgment on gastric cancer].
Lin HZ; Chen L; Li XC; Zhou DF; Cui JY
Zhonghua Wai Ke Za Zhi; 2004 Dec; 42(24):1505-8. PubMed ID: 15733483
[TBL] [Abstract][Full Text] [Related]
8. Effect of betazole on serum group I pepsinogen levels: relationship to gastric acid output in unoperated and postoperative patients.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1977 May; 72(5 Pt 1):845-8. PubMed ID: 849814
[TBL] [Abstract][Full Text] [Related]
9. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach.
Westerveld BD; Pals G; Défize J; Pronk J; Frants RR; Kreuning J; Eriksson AW; Meuwissen SG
Prog Clin Biol Res; 1985; 173():201-12. PubMed ID: 3885251
[TBL] [Abstract][Full Text] [Related]
10. Serum group I pepsinogen levels and their relation to gastric acid secretion in patients with and without recurrent ulcer.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1976 Mar; 70(3):309-13. PubMed ID: 1248696
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.
Miki K; Fujishiro M; Kodashima S; Yahagi N
Dig Endosc; 2009 Apr; 21(2):78-81. PubMed ID: 19691778
[TBL] [Abstract][Full Text] [Related]
12. [A case of a gastric cancer patient with high serum pepsinogen levels at relapse].
Kimura Y; Fujii T; Miyagawa N; Tanada S; Hamamoto K; Kimura S
Gan No Rinsho; 1990 Jul; 36(8):945-8. PubMed ID: 2366328
[TBL] [Abstract][Full Text] [Related]
13. The effect of betazole on serum group I pepsinogen levels: studies in symptomatic patients with and without recurrent ulcer after vagotomy and gastric resection or drainage.
Samloff IM; Secrist DM; Passaro E
Gastroenterology; 1976 Jun; 70(6):1007-13. PubMed ID: 1269860
[TBL] [Abstract][Full Text] [Related]
14. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
15. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
16. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
17. The relation of serum pepsinogen to gastric cancer and its precursors in Hawaii Japanese men: a progress report.
Stemmermann GN; Heilbrun LK; Nomura A; Samloff IM
Prog Clin Biol Res; 1985; 173():213-20. PubMed ID: 3983194
[TBL] [Abstract][Full Text] [Related]
18. Pepsinogens I and II in carcinoma of the stomach: an immunohistochemical study.
Stemmermann GN; Samloff IM; Hayashi T
Appl Pathol; 1985; 3(3):159-63. PubMed ID: 3915949
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of serum pepsinogen and progastricsin in man.
Axelsson CK
Scand J Clin Lab Invest Suppl; 1992; 210():81-96. PubMed ID: 1455183
[TBL] [Abstract][Full Text] [Related]
20. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]